Lidocaine relieves murine allergic rhinitis by regulating the NF-[kappa]B and p38 MAPK pathways
Allergic rhinitis (AR) is one of the most common chronic inflammatory diseases and its main feature is nasal mucositis. It has been recently revealed that lidocaine demonstrates optimal effects in the treatment of various diseases. However, a limited number of studies have examined the association b...
Gespeichert in:
Veröffentlicht in: | Experimental and therapeutic medicine 2022-03, Vol.23 (3) |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!